Publication | Open Access
Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer
72
Citations
40
References
2014
Year
Dual inhibition of STAT3-NF-κB by Nexrutine may overcome problems associated with inhibition of either pathway.
| Year | Citations | |
|---|---|---|
Page 1
Page 1